[Multimodal therapy of functional gastrointestinal disorders].
A multimodal approach is state-of-the art for effective treatment of functional gastrointestinal disorders (FGD) like irritable bowel syndrome and functional dyspepsia. Based on the now established view that the pathogenesis of FGD is multicausal, evidence-based therapeutic options comprise education about the nature of the disorder, dietary modifications, relaxation techniques, behavioral changes, and pharmacological treatments. These therapies are variously combined depending on the severity of the FGD and the individual needs of the patient. Our overview portrays the options for the therapy of FGD and proposes that these are best provided by an interdisciplinary team of primary care physicians, gastroenterologists, and psychosomatic medicine specialists.
Egloff
N
N
Kompetenzbereich für Psychosomatische Medizin, Universitätsklinik für Allgemeine Innere Medizin, Inselspital, Universitätsspital Bern. niklaus.egloff@insel.ch
Beer
C
C
Gschossmann
J M
JM
Sendensky
A
A
von Känel
R
R
D015746:Abdominal Pain / Q000209:etiology; D000928:Antidepressive Agents / Q000627:therapeutic use; D001676:Biofeedback, Psychology; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D004415:Dyspepsia / Q000150:complications / Q000188:drug therapy / Q000523:psychology / Q000628:therapy*; D005247:Feeding Behavior; D005544:Forecasting; D006801:Humans; D007211:Indoles / Q000627:therapeutic use; D043183:Irritable Bowel Syndrome / Q000150:complications / Q000188:drug therapy / Q000628:therapy*; D015201:Meta-Analysis as Topic; D010349:Patient Compliance; D019936:Probiotics / Q000627:therapeutic use; D011613:Psychotherapy; D011788:Quality of Life; D012064:Relaxation Therapy; D017366:Serotonin Receptor Agonists / Q000627:therapeutic use; D013315:Stress, Psychological; D011795:Surveys and Questionnaires
D000928:Antidepressive Agents; D007211:Indoles; D017366:Serotonin Receptor Agonists; C105050:tegaserod